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F. Bastos Gonçalves a,b,*
a Hospital de Santa Marta, CHLC, NOVA University, Lisbon, Portugal
b Erasmus University Medical Center, Rotterdam, The NetherlandsNearly a quarter century after its introduction, and after 15
years of widespread use of endovascular aneurysm repair
(EVAR) for the treatment of abdominal aortic aneurysm
(AAA), the signiﬁcance of type II endoleaks remains unclear.
Although its true incidence is probably much higher than
standard imaging is able to detect,1 only a fraction of
affected patients present with sac expansion.2 Moreover,
rupture caused solely by type II endoleaks is, at best,
exceedingly rare, and growth may occur without visible
endoleaks as well.2 Characteristics of the feeding and
outﬂow arteries, of ﬂow patterns, and of the aneurysm wall
may all inﬂuence sac behavior after implant, but accurate
identiﬁcation of threatening type II endoleaks is, to date,
not realistic.
In the face of this uncertainty, the physician’s attitude
ranges from no treatment irrespective of growth, selective
treatment of type II endoleaks associated with growth, or
treatment of all persistent type II endoleaks. In addition,
catheter based strategies for treatment have high failure
rates and are not exempt from potentially fatal complica-
tions.3 Even less consensus exists for diagnostic workup and
management of growing aneurysms without visible
endoleaks.
Maitrias et al.4 present an open alternative to conversion
for patients with aneurysm expansion after EVAR, consisting
of sacotomy, treatment of the identiﬁed cause of expansion
(not necessarily always type II endoleaks) with graft pres-
ervation and without the mandatory need for extensive
dissection and cross clamping. Their excellent results, if
reproducible, may be adopted as a more deﬁnitive solution
to post-implant growth with reasonable morbidity. Follow
up needs to be longer, however, to draw deﬁnitive con-
clusions on efﬁcacy. Other techniques, such as laparoscopic
sac fenestration, were very promising alternatives for the
same problem but failed to show durable results in the long
term.5DOI of original article: http://dx.doi.org/10.1016/j.ejvs.2015.07.013
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http://dx.doi.org/10.1016/j.ejvs.2015.09.016Intra-operative ﬁndings and their correspondence to
imaging is a very important aspect of this series, illustrating
the current inaccuracy. In more than half the patients, more
vessels were patent than seen on imaging. In one case (of
12) a type III endoleak was newly identiﬁed and in one case
there was no endoleak and the cause of growth remained
endotension. Interestingly, no “occult” type I endoleaks
were revealed.
In conclusion, the proposed solution for post-implant
aneurysm expansion with graft preservation is appealing
and may result in a more deﬁnitive resolution of the un-
derlying cause. If proven durable, it may preferred over less
efﬁcient percutaneous alternatives without the morbidity of
endograft explantation.REFERENCES
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